Form 4: VolitionRx Director Innes Receives 50,000 Restricted Stock Units

Director Guy Archibald Innes of VolitionRx Ltd. was granted 50,000 restricted stock units, according to a recent SEC filing.

Summary

• Guy Archibald Innes, a director at VolitionRx Ltd., received 50,000 restricted stock units (RSUs) on January 15, 2025.
• These RSUs will vest in three installments: 16,667 units on January 15, 2026, 16,667 units on January 15, 2027, and 16,666 units on January 15, 2028.
• Upon vesting, Innes will receive common stock equal to the number of vested RSUs.
• Innes also has indirect beneficial ownership of 1,400,000 shares through The Innes Family Bare Trust 2023, 356,000 shares through The Dill Faulkes Educational Trust Limited, and 154,503 shares each through his two sons and 154,504 shares each through his two daughters.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock units to a director, which is generally positive for aligning interests but not a major market-moving event.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and contribution from the director.

Future Outlook

The director will receive shares of common stock upon the vesting of the RSUs over the next three years.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with shareholders in the biotechnology industry.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice in the biotechnology sector, similar to companies like Exact Sciences (EXAS) and Guardant Health (GH), which also use equity-based compensation.
• The vesting schedule of three years is also typical, aligning with long-term value creation goals, similar to the vesting schedules seen at companies like Illumina (ILMN).
• The size of the grant is not unusual for a director of a company of VolitionRx's size and stage of development, and is comparable to grants made to directors at similar companies.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of shareholders.
• The vesting schedule encourages the director's continued service and contribution to the company.

Next Steps

• The director will receive shares of common stock as the RSUs vest over the next three years.

Key Dates

Keywords

restricted stock units, RSUs, beneficial ownership, director, stock incentive plan, VNRX, VolitionRx